Abstract

Regulated intramembrane proteolysis of the amyloid precursor protein (APP) and its homologs, the APP like proteins APLP1 and APLP2, is typically a two-step process, which is initiated by ectodomain-shedding of the substrates by α- or β-secretases. Growing evidence, however, indicates that the cleavage process for APLP1 is different than for APP. Here, we describe that full-length APLP1, but not APP or APLP2, is uniquely cleaved by γ-secretase without previous ectodomain shedding. The new fragment, termed sAPLP1γ, was exclusively associated with APLP1, not APP, APLP2. We provide an exact molecular analysis showing that sAPLP1γ was uniquely generated by γ-secretase from full-length APLP1. Mass spectrometry analysis showed that the sAPLP1γ fragment and the longest Aβ-like peptide share the C-terminus. This novel mechanism of γ-secretase action is consistent with an ϵ-cut based upon the nature of the reaction in APP. We further demonstrate that the APLP1 transmembrane sequence is the critical determinant for γ-shedding and release of full-length APLP1. Moreover, the APLP1 TMS is sufficient to convert larger type-I membrane proteins like APP into direct γ-secretase substrates. Taken together, the direct cleavage of APLP1 is a novel feature of the γ-secretase prompting a re-thinking of γ-secretase activity modulation as a therapeutic strategy for Alzheimer disease.

Highlights

  • APLP1 is part of an evolutionarily conserved family of type-I transmembrane proteins including the amyloid precursor protein (APP) and APLP2 which are homologous in function[1,2,3,4]

  • While BACE1 has a key role in the regulation of APLP1 maturation, trafficking, and secretion[33], the loss of BACE1 processing of APLP1 has no detrimental effect on the de novo production of AL1ICD24,31

  • The more specific BACE1 inhibitor IV completely abolished the detection of BACE1-mediated soluble APP secretion while the γ-secretase inhibitor L-685,458 had no effect on either sAPP form (Fig. 1a,b)

Read more

Summary

Introduction

APLP1 (amyloid precursor-like protein 1) is part of an evolutionarily conserved family of type-I transmembrane proteins including the amyloid precursor protein (APP) and APLP2 (amyloid precursor-like protein 2) which are homologous in function[1,2,3,4]. APP and APLPs have roles in neuronal differentiation, synaptogenesis, neurite outgrowth, and synaptic plasticity[5,6,7,8,9,10,11,12] These proteins are expressed in different tissues and cell types. Shedding of APP and APLPs by α- or β-secretases (BACE1) results in the generation of membrane-bound C-terminal fragments (CTF) and soluble ectodomains that were recently detected as APP heteromers in human CSF23. Shedding of APP and APLPs by the α- and β-secretases results in the generation of membrane-bound CTFs. CTFs are further processed into ICDs which are postulated to be involved in transcriptional regulation[28,29,30]. Zinc enriches APP family members at sites of cell-cell contacts and revealed a zinc-dependent role of APP/APLPs as neuronal cell adhesion proteins[21]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call